Representation of the Body for Patients With Cancer

NCT01560533 | Completed

• 1 other identifier: 2010.640
• Study Type: interventional
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

The project aims to understand better how patients live the event of cancer and live its consequences on their bodily representations. In the study, the dynamic of the body image is not restricted to appearance but include sensations and visions of the inner body, what explains the choice of peritoneal cancer, and the treatment by cytoreductive surgery and HIPEC. The three objectives of the study are:

• identifying the impact of the representations of the treated body on the psychological strategies to cope with the disease, the bodily changes and the prospects of life;
• making explicit the positive or negative impacts of these representations on the relationship between patients and health professionals (easing factors, misunderstandings, negotiations, etc.);
• associating the health professionals with the study in its course and evaluation in order to elaborate a methodological collaborative approach between patients, health professionals and researchers in social sciences.

Conditions

Peritoneal Carcinomatosis

Outcome Measures

Primary Outcomes (1)

• Body representations

  Comprehensive knowledge concerning the way the patients are living cancer event, treatment, changes in their body representations and conceptions of their lives. This qualitative study do not include outcome measures. Its purpose is restricted to the meanings

  3 months

Study Arms (2)

Treated by HIPEC

OTHER

Patients treated by HIPEC for peritoneal cancer

Behavioral: Interviews

Standard chemiotherapy

OTHER

Patients treated by standard chemiotherapy for peritoneal cancer

Behavioral: Interviews

Interventions

Interviews BEHAVIORAL

Interviews will be done with patients

Standard chemiotherapy; Treated by HIPEC

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC
• Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian) peritoneal cancer
• Free consent
• Male or Female
• Age \> 18 years
• Affiliate to social security

You may not qualify if:

• Age \< 18 years, no french speaking
• Cerebrals metastasis
• Psychiatrics diseases

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, 69495, France

Location

Related Publications (1)

• Durif-Bruckert C, Guilloux R, Guioux A, Lasserre E, Goffette J, Regnier V. [Qualitative and collaborative research with cancer patients. Experience narratives of treatments for peritoneal carcinomatosis]. Bull Cancer. 2016 Feb;103(2):148-53. doi: 10.1016/j.bulcan.2015.10.015. Epub 2015 Dec 8. French.

  PMID: 26681640 RESULT

MeSH Terms

Conditions

Peritoneal Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Abdominal Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Peritoneal Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Olivier GLEHEN, Pr

  Hospices Civiles de Lyon

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 12, 2011
• First Posted: March 22, 2012
• Study Start: November 1, 2011
• Primary Completion: January 1, 2013
• Study Completion: January 1, 2013
• Last Updated: May 28, 2019

Record last verified: 2014-01

Locations

FR (1)